MYCN Enhances P-gp/MDR1 Gene Expression in the Human Metastatic Neuroblastoma IGR-N-91 Model
- 1 July 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (1) , 321-331
- https://doi.org/10.1016/s0002-9440(10)63656-5
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Apoptosis: A Link between Cancer Genetics and ChemotherapyPublished by Elsevier ,2002
- Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1Journal of Biological Chemistry, 2001
- Cloning and characterization of a novel transcription factor involved in cellular proliferation arrest: PATFOncogene, 2001
- In Vivo Elimination of Acentric Double Minutes Containing Amplified MYCN from Neuroblastoma Tumor Cells Through the Formation of MicronucleiThe American Journal of Pathology, 2001
- Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cellsJournal of Clinical Investigation, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastomaEuropean Journal Of Cancer, 1997
- Molecular basis for heterogeneity in human neuroblastomasEuropean Journal Of Cancer, 1995
- The mycn/max protein complex in neuroblastoma. Short reviewEuropean Journal Of Cancer, 1995
- Correlation of MDR1 Gene Expression With Chemotherapy in NeuroblastomaJNCI Journal of the National Cancer Institute, 1989